ClinicalTrials.gov
public full text
Public Domain
Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old
This study focus on the comparison of CAG regimen to the low dose cytarabine therapy in elderly AML patients who are unfit or unwilling to receive intensive chemotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients#890267
- Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients#1046078
- Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60#848702
- A Phase II Study of the FIL on Elderly Frail Patients With DLBCL#856849
- Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL#867745
Record · ID 1140007
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive